Meng and colleagues evaluated angiogenesis in hepatocellular carcinoma following HSP90α or HSP90β knockdown and observed that HSP90β inhibitors inhibited VEGFR-mediated angiogenesis [50,51]. The gene discussed is HSP90AA1; the disease is hepatocellular carcinoma.